STAT1 as a downstream mediator of ERK signaling contributes to bone cancer pain by regulating MHC II expression in spinal microglia
Zhenpeng Song(Nanjing University of Posts and Telecommunications), Yuke Tian(Tongji Hospital), Anne Manyande(University of West London), Bingrui Xiong(Wuhan University), Hua Zheng(Harvard University), Lifang Ren(Tongji Hospital), Fei Cao(Tongji Hospital), Xuehai Guan(First Affiliated Hospital of GuangXi Medical University), Dawei Ye(Tongji Hospital), Ya‐Qun Zhou(Tongji Hospital)
Cited by 56
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Non-pharmacological interventions for assisting the induction of anaesthesia in children
|Cochrane Database of Systematic Reviews|2015|329
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
|Trends in Pharmacological Sciences|2020|304
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138